countries News newsbot.ch

Wirtschaft »

Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer

Roche presents positive Phase III results for Tecentriq® (atezolizumab) in combination with platinum-based chemotherapy in people with previously untreated advanced bladder cancer

2019-09-30 19:20:02


Wirtschaft »

Roche to present results of first prospective trial using blood-based next generation sequencing which successfully identifies people for treatment with Alecensa

2019-09-30 07:20:03


Wirtschaft »

FDA approves Roche’s Rituxan (rituximab) in children with two rare blood vessel disorders

2019-09-30 07:20:03


Wirtschaft »

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

2019-09-28 06:20:30


Wirtschaft »

Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma

2019-09-27 14:20:09


Inland »

High-Level Meeting zur Syrien-Krise, organisiert von der EU (fr/en)

2019-09-25 11:52:05


Inland »

High-Level Meeting zur Syrien-Krise, organisiert von der EU (en)

2019-09-24 20:53:34


Inland »

Eröffnungszeremonie für das neue Generalkonsulat in Chicago (en)

2019-09-23 18:52:21


Wirtschaft »

Roche to present new data from its broad oncology portfolio at the European Society for Medical Oncology 2019 Congress

2019-09-23 07:20:16


Wirtschaft »

FDA approves cobas Babesia, Roche’s first whole blood test for donor screening

2019-09-20 07:40:10


Wirtschaft »

FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis

2019-09-18 05:20:01


Wirtschaft »

Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients

2019-09-16 05:20:45


Wirtschaft »

Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

2019-09-13 13:20:50


Wirtschaft »

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer

2019-09-13 13:20:50


Wirtschaft »

Roche’s satralizumab significantly reduced relapse risk in second  positive phase III study for neuromyelitis optica spectrum

Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum

2019-09-12 13:20:00


Wirtschaft »

Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy

2019-09-12 13:20:00


Wirtschaft »

Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS

2019-09-10 05:40:12


Wirtschaft »

European Commission approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of people with extensive-stage small cell lung cancer

2019-09-06 06:20:00


Wirtschaft »

European Commission approves Roche’s new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer

2019-09-06 06:20:00


Wirtschaft »

Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS

2019-09-04 06:40:12



Suchresultate als RSS-Feed